Literature DB >> 9449586

Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis.

A Rosamilia1, P L Dwyer, J Gibson.   

Abstract

Electromotive drug administration (EMDA) involves the active transport of ionized drugs such as lidocaine by the application of an electric current. Twenty-one female subjects with interstitial cystitis were treated with EMDA of lidocaine and dexamethasone, followed by cystodistension. The procedure was convenient and well tolerated, with hospital attendance for 1 hour. Bladder anesthesia was excellent, with cystodistension from a discomfort level of 200 ml to a mean volume of 600 ml. Eighty-five percent had a good response (reduction in frequency and in pain score by 3 or more) at 2 weeks, with 63% still responding at 2 months. An excellent response (pain score of 0) was present in 25% of patients reviewed at 6 months. These results are comparable to the response following cystodistension under general anesthesia. There is a need for a randomized blinded comparison of lidocaine with and without EMDA. If proven to be of pharmacological efficacy, EMDA would have many applications in facilitating procedures previously requiring general anesthesia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9449586     DOI: 10.1007/bf02764846

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  16 in total

1.  Interstitial cystitis: early diagnosis, pathology, and treatment.

Authors:  E M Messing; T A Stamey
Journal:  Urology       Date:  1978-10       Impact factor: 2.649

2.  Use of amitriptyline in the treatment of interstitial cystitis.

Authors:  P M Hanno; J Buehler; A J Wein
Journal:  J Urol       Date:  1989-04       Impact factor: 7.450

Review 3.  Standard intravesical therapies for interstitial cystitis.

Authors:  G R Sant; D R LaRock
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

Review 4.  The importance of placebo effects in pain treatment and research.

Authors:  J A Turner; R A Deyo; J D Loeser; M Von Korff; W E Fordyce
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

5.  Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study.

Authors:  M Lazzeri; P Beneforti; G Benaim; C A Maggi; A Lecci; D Turini
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

6.  Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.

Authors:  A Morales; L Emerson; J C Nickel; M Lundie
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

7.  Cimetidine in the treatment of interstitial cystitis.

Authors:  P Seshadri; L Emerson; A Morales
Journal:  Urology       Date:  1994-10       Impact factor: 2.649

8.  A controlled study of dimethyl sulfoxide in interstitial cystitis.

Authors:  R Perez-Marrero; L E Emerson; J T Feltis
Journal:  J Urol       Date:  1988-07       Impact factor: 7.450

Review 9.  Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis.

Authors:  M Fall; S Lindström
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

10.  Electromotive administration of a new morphine formulation: morphine citrate.

Authors:  R Stephen; D Miotti; R Bettaglio; C Rossi; C Bonezzi
Journal:  Artif Organs       Date:  1994-06       Impact factor: 3.094

View more
  9 in total

Review 1.  Treatment of bladder pain syndrome and interstitial cystitis: a systematic review.

Authors:  Carolina Pazin; Andréia Moreira de Souza Mitidieri; Ana Paula Moreira Silva; Maria Beatriz Ferreira Gurian; Omero Benedicto Poli-Neto; Julio Cesar Rosa-E-Silva
Journal:  Int Urogynecol J       Date:  2015-08-14       Impact factor: 2.894

Review 2.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

3.  [Intravesical therapy for overactive bladder].

Authors:  J Pannek; U Grigoleit; R Wormland; M Goepel
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

4.  Interstitial cystitis: new development and a proposal for the IUGA. International Urogynecological Association.

Authors:  J S Gibson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

5.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

Review 6.  [Diagnosis and treatment of interstitial cystitis (IC/PBS) : S2k guideline of the German Society of Urology].

Authors:  T Bschleipfer; R Doggweiler; D Schultz-Lampel; J de Jong; A Gonsior; J Hensen; E Heßdörfer; B T Kaftan; A Kuhn; U Kunzendorf; A Lampel; A Landmesser; A Loch; O Moormann; B Müller; J Neuhaus; A Reich; R Roth; S Schumacher; R Stratmeyer; W Vahlensieck; A Wördehoff; B Münder-Hensen
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

Review 7.  Intravesical treatments of bladder pain syndrome/interstitial cystitis.

Authors:  Jochen Neuhaus; Thilo Schwalenberg
Journal:  Nat Rev Urol       Date:  2012-11-27       Impact factor: 14.432

8.  Office bladder distention with electromotive drug administration (EMDA) is equivalent to distention under general anesthesia (GA).

Authors:  Amy E Rose; Kathryn J Azevedo; Christopher K Payne
Journal:  BMC Urol       Date:  2005-11-22       Impact factor: 2.264

9.  Instillation of Hyaluronic Acid via Electromotive Drug Administration Can Improve the Efficacy of Treatment in Patients With Interstitial Cystitis/Painful Bladder Syndrome: A Randomized Prospective Study.

Authors:  Omer Gülpınar; Ahmet Hakan Haliloğlu; Mehmet İlker Gökce; Nihat Arıkan
Journal:  Korean J Urol       Date:  2014-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.